HOTH

Neutral

Cancer patients stayed on treatment as Hoth trial eased rash

Hoth Therapeutics secured regulatory authorization in Spain for its Phase 2a CLEER trial of HT-001 and reported positive interim data. The trial showe...

Stock Titan 6 days ago 0

Bullish

Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients

Hoth Therapeutics has received regulatory authorization in Spain for its HT-001 Phase 2a CLEER Trial, indicating a significant step in its European st...

The AI Journal 6 days ago 0

Bullish

Hoth Therapeutics Reports Positive HT VA Study Data Highlighting GDNF Driven Metabolic Reprogramming In Fatty Liver Disease

Hoth Therapeutics announced positive data from its HT-VA study, revealing that GDNF can reprogram liver fat metabolism at the genetic level in metabol...

BioPharma APAC 3 weeks ago 0